Cargando…

Novel Biphasic Role of Resolvin D1 on Expression of Cyclooxygenase-2 in Lipopolysaccharide-Stimulated Lung Fibroblasts Is Partly through PI3K/AKT and ERK2 Pathways

Fibroblasts, far frombeing merely bystander cells, are known to play a specific role in inflammation resolution after an acute injury. As the endogenous “braking signal,” resolvins possess potent anti-inflammatory and proresolution actions. We demonstrated that the expression of COX-2 protein was si...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Derong, Zheng, Shengxing, Li, Wenjuan, Yang, Li, Liu, Yongjian, Zheng, Xia, Yang, Yi, Yang, Liangmin, Wang, Qian, Smith, Fang Gao, Jin, Shengwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794569/
https://www.ncbi.nlm.nih.gov/pubmed/24174713
http://dx.doi.org/10.1155/2013/964012
_version_ 1782287219927547904
author Wu, Derong
Zheng, Shengxing
Li, Wenjuan
Yang, Li
Liu, Yongjian
Zheng, Xia
Yang, Yi
Yang, Liangmin
Wang, Qian
Smith, Fang Gao
Jin, Shengwei
author_facet Wu, Derong
Zheng, Shengxing
Li, Wenjuan
Yang, Li
Liu, Yongjian
Zheng, Xia
Yang, Yi
Yang, Liangmin
Wang, Qian
Smith, Fang Gao
Jin, Shengwei
author_sort Wu, Derong
collection PubMed
description Fibroblasts, far frombeing merely bystander cells, are known to play a specific role in inflammation resolution after an acute injury. As the endogenous “braking signal,” resolvins possess potent anti-inflammatory and proresolution actions. We demonstrated that the expression of COX-2 protein was significantly peaked initially at 6 hours but then also at 48 hours after LPS stimulation in lung fibroblasts. PGE(2) levels also peaked at 6 hours, and PGD(2) levels were increased and peaked at 48 hours. However, no significant change in the protein expression of COX-1 was observed after treatment with LPS in lung fibroblasts. Exogenous resolvin D1 inhibited the first peak of COX-2 expression as well as the production of PGE(2) induced by LPS. In contrast, exogenous resolvin D1 increased the second peak of COX-2 expression as well as the production of PGD(2) induced by LPS. In addition, resolvin D1 inhibited COX-2 expression at 6 hours, which was partly through PI3K/AKT and ERK2 signalling pathways.
format Online
Article
Text
id pubmed-3794569
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-37945692013-10-30 Novel Biphasic Role of Resolvin D1 on Expression of Cyclooxygenase-2 in Lipopolysaccharide-Stimulated Lung Fibroblasts Is Partly through PI3K/AKT and ERK2 Pathways Wu, Derong Zheng, Shengxing Li, Wenjuan Yang, Li Liu, Yongjian Zheng, Xia Yang, Yi Yang, Liangmin Wang, Qian Smith, Fang Gao Jin, Shengwei Mediators Inflamm Research Article Fibroblasts, far frombeing merely bystander cells, are known to play a specific role in inflammation resolution after an acute injury. As the endogenous “braking signal,” resolvins possess potent anti-inflammatory and proresolution actions. We demonstrated that the expression of COX-2 protein was significantly peaked initially at 6 hours but then also at 48 hours after LPS stimulation in lung fibroblasts. PGE(2) levels also peaked at 6 hours, and PGD(2) levels were increased and peaked at 48 hours. However, no significant change in the protein expression of COX-1 was observed after treatment with LPS in lung fibroblasts. Exogenous resolvin D1 inhibited the first peak of COX-2 expression as well as the production of PGE(2) induced by LPS. In contrast, exogenous resolvin D1 increased the second peak of COX-2 expression as well as the production of PGD(2) induced by LPS. In addition, resolvin D1 inhibited COX-2 expression at 6 hours, which was partly through PI3K/AKT and ERK2 signalling pathways. Hindawi Publishing Corporation 2013 2013-09-23 /pmc/articles/PMC3794569/ /pubmed/24174713 http://dx.doi.org/10.1155/2013/964012 Text en Copyright © 2013 Derong Wu et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Wu, Derong
Zheng, Shengxing
Li, Wenjuan
Yang, Li
Liu, Yongjian
Zheng, Xia
Yang, Yi
Yang, Liangmin
Wang, Qian
Smith, Fang Gao
Jin, Shengwei
Novel Biphasic Role of Resolvin D1 on Expression of Cyclooxygenase-2 in Lipopolysaccharide-Stimulated Lung Fibroblasts Is Partly through PI3K/AKT and ERK2 Pathways
title Novel Biphasic Role of Resolvin D1 on Expression of Cyclooxygenase-2 in Lipopolysaccharide-Stimulated Lung Fibroblasts Is Partly through PI3K/AKT and ERK2 Pathways
title_full Novel Biphasic Role of Resolvin D1 on Expression of Cyclooxygenase-2 in Lipopolysaccharide-Stimulated Lung Fibroblasts Is Partly through PI3K/AKT and ERK2 Pathways
title_fullStr Novel Biphasic Role of Resolvin D1 on Expression of Cyclooxygenase-2 in Lipopolysaccharide-Stimulated Lung Fibroblasts Is Partly through PI3K/AKT and ERK2 Pathways
title_full_unstemmed Novel Biphasic Role of Resolvin D1 on Expression of Cyclooxygenase-2 in Lipopolysaccharide-Stimulated Lung Fibroblasts Is Partly through PI3K/AKT and ERK2 Pathways
title_short Novel Biphasic Role of Resolvin D1 on Expression of Cyclooxygenase-2 in Lipopolysaccharide-Stimulated Lung Fibroblasts Is Partly through PI3K/AKT and ERK2 Pathways
title_sort novel biphasic role of resolvin d1 on expression of cyclooxygenase-2 in lipopolysaccharide-stimulated lung fibroblasts is partly through pi3k/akt and erk2 pathways
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794569/
https://www.ncbi.nlm.nih.gov/pubmed/24174713
http://dx.doi.org/10.1155/2013/964012
work_keys_str_mv AT wuderong novelbiphasicroleofresolvind1onexpressionofcyclooxygenase2inlipopolysaccharidestimulatedlungfibroblastsispartlythroughpi3kaktanderk2pathways
AT zhengshengxing novelbiphasicroleofresolvind1onexpressionofcyclooxygenase2inlipopolysaccharidestimulatedlungfibroblastsispartlythroughpi3kaktanderk2pathways
AT liwenjuan novelbiphasicroleofresolvind1onexpressionofcyclooxygenase2inlipopolysaccharidestimulatedlungfibroblastsispartlythroughpi3kaktanderk2pathways
AT yangli novelbiphasicroleofresolvind1onexpressionofcyclooxygenase2inlipopolysaccharidestimulatedlungfibroblastsispartlythroughpi3kaktanderk2pathways
AT liuyongjian novelbiphasicroleofresolvind1onexpressionofcyclooxygenase2inlipopolysaccharidestimulatedlungfibroblastsispartlythroughpi3kaktanderk2pathways
AT zhengxia novelbiphasicroleofresolvind1onexpressionofcyclooxygenase2inlipopolysaccharidestimulatedlungfibroblastsispartlythroughpi3kaktanderk2pathways
AT yangyi novelbiphasicroleofresolvind1onexpressionofcyclooxygenase2inlipopolysaccharidestimulatedlungfibroblastsispartlythroughpi3kaktanderk2pathways
AT yangliangmin novelbiphasicroleofresolvind1onexpressionofcyclooxygenase2inlipopolysaccharidestimulatedlungfibroblastsispartlythroughpi3kaktanderk2pathways
AT wangqian novelbiphasicroleofresolvind1onexpressionofcyclooxygenase2inlipopolysaccharidestimulatedlungfibroblastsispartlythroughpi3kaktanderk2pathways
AT smithfanggao novelbiphasicroleofresolvind1onexpressionofcyclooxygenase2inlipopolysaccharidestimulatedlungfibroblastsispartlythroughpi3kaktanderk2pathways
AT jinshengwei novelbiphasicroleofresolvind1onexpressionofcyclooxygenase2inlipopolysaccharidestimulatedlungfibroblastsispartlythroughpi3kaktanderk2pathways